Veradermics, Inc: Longitude Capital Partners V, LLC amends Schedule 13D stake filing

Longitude Capital Partners V, LLC amended its Schedule 13D stake filing for Veradermics, Inc., according to SEC accession 0001193125-26-461091. The amendment updates the fund's previously reported beneficial ownership position in the company. Schedule 13D filings are required when an investor holds more than 5% of a company's voting shares and intends to remain active, making the disclosure a signal of the fund's continued strategic interest. The filing did not disclose a change in control or a new agreement. Investors will watch for further 13D amendments that reveal whether Longitude adds to or trims its position.